Sevoflurane causes greater QTc interval prolongation in elderly patients than in younger patients

Anesthesia and Analgesia

Volumn 110, Issue 3, 2010, Pages 775-779

  Nakao, Shinichi ^a   Hatano, Kiyohiko ^a   Sumi, Chisato ^a   Masuzawa, Munehiro ^a   Sakamoto, Sachiyo ^a   Ikeda, Sakahiro ^a   Shingu, Koh ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DROPERIDOL; SEVOFLURANE;

ADULT; AGED; ANESTHESIA; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; T WAVE;

EID: 77949294173     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181cde713     Document Type: Article

References (53)

1. McKechnie RS, Smith D, Montoye C, Kline-Rogers E, O'Donnell MJ, DeFranco AC, Meengs WL, McNamara R, McGinnity JG, Patel K, Share D, Riba A, Khanal S, Moscucci M; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation 2004; 110: 271-277
2. 2. Voeltz MD, Patel AD, Feit F, Fazel R, Lineoff AM, Manoukian SV. Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary intervention. Am J Cardiol 2007; 99: 1513-1517 (Pubitemid 46770636)
3. 3. Gurm HS, Lincoff AM, Kleiman NS, Kereiakes DJ, Tcheng JE, Aronow HD, Askari AT, Brennan DM, Topol EJ. Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions. Am J Cardiol 2004; 94: 30-34 (Pubitemid 38813449)
4. 4. Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH, Gibson CM, Braunwald E. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005; 111: 2042-2049 (Pubitemid 40577898)
5. 5. Nikolsky E, Aymong ED, Halkin A, Grines CL, Cox DA, Garcia E, Mehran R, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Cohen DA, Negoita M, Lansky AJ, Stone GW. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol 2004; 44: 547-553 (Pubitemid 39078177)
6. 6. Lee PC, Kini AS, Ahsan C, Fisher E, Sharma SK. Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol 2004; 44: 541-546 (Pubitemid 39078176)
7. 7. Halkin A, Singh M, Nikolsky E, Grines CL, Tcheng JE, Garcia E, Cox DA, Turco M, Stuckey TD, Na Y, Lansky AJ, Gersh BJ, O'Neill WW, Mehran R, Stone GW. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 2005; 45: 1397-1405 (Pubitemid 40615609)
8. Keough-Ryan TM, Kiberd BA, Dipchand CS, Cox JL, Rose CL, Thompson KJ, Clase CM. Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia. Am J Kidney Dis 2005; 46: 845-855
9. 9. Naidech AM, Drescher J, Ault ML, Shaibani A, Batjer HH, Alberts MJ. Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage. Neurosurgery 2006; 59: 775-9; discussion 779-780 (Pubitemid 44579594)
10. 10. McMahon LP, McKenna MJ, Sangkabutra T, Mason K, Sostaric S, Skinner SL, Burge C, Murphy B, Crankshaw D. Physical performance and associated electrolyte changes after haemoglobin normalization: a comparative study in haemodialysis patients. Nephrol Dial Transplant 1999; 14: 1182-1187 (Pubitemid 29209305)
11. 11. Vaiciuniene R, Kuzminskis V, Dvaranauskaite L, Juocaite K, Cesnovaite V. Influence of anemia on hospitalization and mortality in hemodialysis patients. Medicina (Kaunas) 2005; 41(suppl 1): 60-64 (Pubitemid 43168809)
12. 12. Moinar MZ, Czira M, Ambrus C, Szeifert L, Szentkiralyi A, Beko G, Rosivall L, Remport A, Novak M, Mucsi I. Anemia is associated with mortality in kidney-transplanted patients-a prospective cohort study. Am J Transplant 2007; 7: 818-824 (Pubitemid 46481205)
13. Kaufman DB, Sutherland DE, Fryd DS, Asher NL, Simmons RL, Najarian JS. A single-center experience of renal transplantation in thirteen Jehovah's Witnesses. Transplantation 1998; 45: 1045-1049
14. Hebert PC, Wells G, Tweeddale M, Martin C, Marshall J, Pham B, Blajchman M, Schweitzer I, Pagliarello G. Does transfusion practice affect mortality in critically ill patients? Am J Respir Crit Care Med 1997; 155: 1618-1623
15. 15. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, MacIntyre NR, Shabot MM, Duh MS, Shapiro MJ. The CRIT study: anemia and blood transfusion in the critically ill-clinical practice in the United States. Crit Care Med 2004; 32: 39-52 (Pubitemid 38125561)
16. 16. Dunne JR, Malone D, Tracy JK, Gannon C, Napolitano LM. Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res 2002; 102: 237-244 (Pubitemid 34969473)
17. 17. Culleton BF, Manns BJ, Zhang J, Tonelli M, Klarenbach S, Hemmelgarn BR. Impact of anemia on hospitalization and mortality in older adults. Blood 2006; 107: 3841-3846 (Pubitemid 43726785)
18. 18. Hamel MB, Henderson WG, Khuri SF, Daley J. Surgical outcomes for patients aged 80 and older: morbidity and mortality from major noncardiac surgery. J Am Geriatr Soc 2005; 53: 424-429 (Pubitemid 41623520)
19. 19. Wu WC, Schifftner TL, Henderson WG, Eaton CB, Poses RM, Uttley G, Sharma SC, Vezeridis M, Khuri SF, Friedmann PD. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007; 297: 2481-2488 (Pubitemid 46953401)
20. Gruson KI, Aharonoff GB, Egol KA, Zuckerman JD, Koval KJ. The relationship between admission hemoglobin level and outcome after hip fracture. J Orthop Trauma 2002; 16: 39-44
21. 21. Halm EA, Wang JJ, Boockvar K, Penrod J, Silberzweig SB, Magaziner J, Koval KJ, Siu AL. The effect of perioperative anemia on clinical and functional outcomes in patients with hip fracture. J Orthop Trauma 2004; 18: 369-374 (Pubitemid 39069625)
22. Hemopure®[package insert]. South Africa: S. A. Biopure (PTY) LTD, 2001
23. Estep T, Bucci E, Farmer M, Greenburg G, Harrington J, Kim HW, Klein H, Mitchell P, Nemo G, Olsen K, Palmer A, Valeri CR, Winslow R. Basic science focus on blood substitutes: a summary of the NHLBI Division of Blood Diseases and Resources Working group Workshop, March 1, 2006. Transfusion 2008; 48: 776-782
24. 24. Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death. JAMA 2008; 299: 2324-2332 (Pubitemid 351724397)
25. Keipert PE, Olofsson C, Winslow RM. Hemoglobin-based blood substitutes and risk of myocardial infarction and death [Letter]. JAMA 2008; 300: 1295-1296
26. Levien LJ, Hodgson RE, James MF. Hemoglobin-based blood substitutes and risk of myocardial infarction and death [Letter]. JAMA 2008; 300: 1295
27. Shander A, Javidroozi M, Thompson G. Hemoglobin-based blood substitutes and risk of myocardial infarction and death [Letter]. JAMA 2008; 300: 1296-1297
28. Sauala A, Moore EE, Banerjee A. Hemoglobin-based blood substitutes and risk of myocardial infarction and death [Letter]. JAMA 2008; 300: 1297
29. Serruys PW, Vranckx P, Slagboom T, Regar E, Meliga E, de Winter RJ, Heyndrickx G, Schuler G, van Remortel EAM, Dube GP, Symons J; for the COR-001 trial investigators. Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD. EuroIntervention 2008; 3: 600-609
30. Jahr JS, Mackenzie C, Pearce LB, Pitman A, Greenburg AG. HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery. J Trauma 2008; 64: 1484-1497
31. 31. Sprung J, Kindscher JD, Wahr JA, Levy JH, Monk TG, Moritz MW, O'Hara PJ. The use of bovine hemoglobin glutamer-250 (Hemopure®) in surgical patients: results of a multicenter, randomized, single-blinded trial. Anesth Analg 2002; 94: 799-808 (Pubitemid 34263719)
32. Levy JH, Goodnough LT, Greilich PE, Parr GV, Stewart RW, Gratz I, Wahr J, Williams J, Comunale ME, Doblar D, Silvay G, Cohen M, Jahr JS, Vlahakes GJ. Polymerized bovine haemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. J Thorac Cardiovasc Surg 2002; 124: 35-42
33. 33. LaMuraglia GM, O'Hara PJ, Baker WH, Naslund TC, Norris EJ, Li J, Vandermeersch E. The reduction of the allogenic transfusion requirment in aortic surgery with a hemoglobin-based solution. J Vase Surg 2000; 31: 299-308 (Pubitemid 30100040)
34. Levien LJ. South Africa: clinical experience with Hemopure. ISBT Sci Ser 2006; 1: 167-173
35. Callas DD, Clark TL, Moreira PL, Lansden C, Gawryl MS, Kahn S, Bermes EW Jr. In vitro effects of a novel hemoglobinbased oxygen carrier on routine chemistry, therapeutic drug, coagulation, hematology, and blood bank assays. Clin Chem 1997; 43: 1744-1748
36. Moon-Massat PF, Tierney JP, Hock KG, Scott MG. Hitachi Hemolytic Index correlates with HBOC-201 concentrations: impact on suppression of analyte results. Clin Biochem 2008; 41: 432-435
37. 37. Wolthuis A, Peek D, Scholten R, Moreira P, Gawryl M, Clark T, Westerhuis L. Effect of the hemoglobin-based oxygen carrier HBOC-201 on laboratory instrumentation: cobas integra, chiron blood gas analyzer 840, Sysmex SE-9000 and BCT. Clin Chem Lab Med 1999; 37: 71-76 (Pubitemid 29097257)
38. Pearce LB, Pitman AN. Risk of Adverse outcome due to acute anemia in the orthopedic surgical setting. American Society for Clinical Pharmacology and Therapeutics Annual Meeting, Orlando, 2008. Abstract 08-A-451
39. McClelland DBL, ed. Handbook of Transfusion Med. United Kingdom Blood Services, 4th ed. London, England: TSO (The Stationery Office), 2007
40. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006; 105: 198-208
41. 41. Spence RK, Carson JL, Poses R, McCoy S, Pello M, Alexander J, Popovich J, Norcross E. Elective surgery without transfusion: influence of preoperative hemoglobin level and blood loss on mortality. Am J Surg 1990; 159: 320-324 (Pubitemid 20086611)
42. 42. Carson JL, Hill S, Carless P, Herbert P, Henry D. Transfusion triggers: a systematic review of the literature. Transfus Med Rev 2002; 16: 187-199 (Pubitemid 34686541)
43. 43. Stefan DC, Uys R, Wessels G. Hemopure transfusion in a child with severe anemia. Pediatr Hematol Oncol 2007; 24: 269-273 (Pubitemid 47026968)
44. 44. Agrawal YP, Freedman M, Szczepiorkowski ZM. Long-term transfusion of polymerized bovine hemoglobin in a Jehovah's Witness following chemotherapy for myeloid leukemia: a case report. Transfusion 2005; 45: 1735-1738 (Pubitemid 43923900)
45. Gannon CJ, Napolitano LM. Severe anemia after gastrointestinal hemorrhage in a Jehovah's Witness: new treatment strategies. Crit Care Med 2002; 30: 1893-1895
46. 46. Million J, Giacoppe G, Clagett C, McCune D, Dillard T. Transfusions of polymerized bovine hemoglobin in a patient with severe autoimmune hemolytic anemia. N Engl J Med 2000; 342: 1638-1643 (Pubitemid 30341533)
47. Knottenbelt JD. Low initial hemoglobin levels in trauma patients: an important indicator of ongoing hemorrhage. J Trauma 1991; 31: 1396-1399
48. Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 2002; 42: 812-818
49. 49. Carson JL, Poses RM, Spence RK, Bonavita G. Severity of anaemia and operative mortality and morbidity. Lancet 1988; 1: 727-729 (Pubitemid 18075693)
50. Lunn JN, Elwood PC. Anaemia and surgery. Br Med J 1970; 3: 71-73
51. Gould SA. The life-sustaining capacity of human polymerized haemoglobin when red cells might be unavailable. J Am Coll Surg 2002; 195: 445-455
52. Viele MK, Weiskopf RB. What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses. Transfusion 1994; 34: 396-401
53. Moore EE, Moore FA, Fabian TC, Bernard AC, Fulda GJ, Hoyt DB, Duane TM, Weireter LJ Jr, Gomez GA, Cipolle MD, Rodman GH Jr, Malangoni MA, Hides GA, Omert LA, Gould SA; PolyHeme Study Group. Human Polymerized Hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg 2009; 208: 1-13